Skip to main content

Artivion, Inc.

AORT
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000784199

In the last 90 days, Artivion, Inc. insiders filed 0 open-market purchases and 6 sales; 206 institutions reported holding it in 13F filings for Q2 2026, worth $1.03B in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Artivion, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of AORT: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders131135+4
Shares32.2M32.1M−65.3K (−0.2%)
Value$913.2M$715.2M−$197.9M (−21.7%)

New holders (14)

Institutions that held Artivion, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to AORT in Q3 2021
InstitutionSharesValue% of portfolio
SG Americas Securities, LLC55,695$1.24M0.01%
Tudor Investment Corp Et Al41,774$931.0K0.02%
Maryland State Retirement & Pension System15,538$355.0K0.01%
Gsa Capital Partners LLP15,512$346.0K0.04%
Marshall Wace North America L.P.12,705$283.0K0.00%
Occudo Quantitative Strategies LP9,478$211.0K0.03%
Trexquant Investment LP9,396$209.0K0.02%
Northwestern Mutual Wealth Management Co1,200$27.0K0.00%
Lazard Asset Management LLC1,256$27.0K0.00%
Clearstead Advisors, LLC594$13.0K0.00%
PSI Advisors, LLC390$9.00K0.00%
Fifth Third Bancorp73$2.00K0.00%
Rockefeller Capital Management L.P.100$2.00K0.00%
Quadrant Capital Group LLC22$00.00%

Sold out (10)

Institutions that held Artivion, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.